Liraglutide Cost: List Price, Coupons, Insurance, Compounding

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Liraglutide cost is among the most-searched GLP-1 questions, and the honest answer has several moving parts. This PlexusDx Education Hub guide breaks down the published list price, savings programs, insurance realities, the compounding shift of 2024 to 2025, and what typical out-of-pocket scenarios actually look like. Browse all Peptides & GLP-1 education for related explainers.

The published list price

Liraglutide list price is approximately $815 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. List price is rarely what an insured patient pays — it is the starting point before insurance, rebates, manufacturer savings cards, and pharmacy negotiation. What lands at the counter depends on your plan, formulary, prior authorization, and the indication written on the prescription.

Insurance and prior authorization

Whether a commercial plan covers liraglutide hinges on the FDA-approved indication and the plan's own formulary and prior-authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while coverage for chronic weight management varies far more and is often subject to BMI-based prior authorization. Some plans exclude weight-management indications entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products.

Manufacturer savings programs

Novo Nordisk publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance. Savings cards carry monthly and annual caps, and both eligibility and amounts change, so verify current terms on the manufacturer website at the time of fill. Independent platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy.

What changed with compounding in 2024 and 2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of those molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified, and compounded products are priced separately from FDA-approved brands.

Typical out-of-pocket scenarios

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. Without coverage for the indication, cash-pay cost sits closer to list price minus any coupon. Without insurance, cash-pay approaches list price, while compounded alternatives through PlexusDx Weight Management Protocols carry a separate pricing structure published on each product page.

The genetic layer beneath the price

Cost answers what you pay; genetics informs how the underlying biology is set up. PlexusDx does not sell or prescribe liraglutide, but whichever GLP-1 compound you eventually discuss, the architecture is shared. Variants in FTO, GLP1R, MC4R, and TCF7L2 shape baseline GLP-1 signaling and energy balance. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including those variants.

Pulling these threads together explains why quoted prices online vary so widely. A single molecule can appear near list price for an uninsured cash payer, near $25 for a commercially insured patient with a savings card and a covered indication, and somewhere in between when a coupon platform is applied. The compounding shift added another layer: as the FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, the window for compounded formulations narrowed even though legitimate pathways persist where clinically justified. None of these numbers is universal, which is the whole point. The dependable move is to verify your specific price with your pharmacy against your specific plan before you fill, rather than trusting a figure quoted for someone in a different coverage situation.

Related reading on PlexusDx: Victoza Cost, Victoza Dosing, Victoza Generic.

Frequently Asked Questions

How much does liraglutide cost per month?

Liraglutide list price is approximately $815 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. That figure is a starting point, not what most insured patients actually pay. Insurance, savings cards, and pharmacy pricing can substantially change the counter price, so verify current cost with the pharmacy before filling.

Will my insurance cover liraglutide?

Coverage depends on your plan, formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight management coverage is more variable and sometimes excluded. Medicare does not cover weight-management indications for weight alone as of April 2026. Confirm directly with your plan.

Are there coupons or savings cards?

Novo Nordisk publishes a manufacturer savings card for commercially insured patients who meet eligibility criteria, and independent platforms such as GoodRx publish discount prices that vary by pharmacy. Government-insurance patients are typically excluded from manufacturer cards. Because terms and caps change, check the manufacturer site for current details at the time of fill.

Are there lower-cost alternatives?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from FDA-approved brands. These compounded products are legally and factually different — not identical and not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with per-protocol pricing published on each product page for you to review.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.